AVE avecho biotechnology limited

Ann: Avecho & Sandoz Sign Deal to Develop CBD for Insomnia in AUS, page-18

  1. 3,009 Posts.
    lightbulb Created with Sketch. 818
    I'm struggling to get my head around this.
    they have the upfront payment - check
    they get $16 million to meet developments before commercialisation - that company changing - check
    once selling they are going to have regular income from royalties in millions - check
    sandoz purchases from ave - tpm and capsule revenue - check
    ave has kept ROW rights
    AND
    this is only for insomnia. Ave could potentially do a deal for anxiety etc
    finally 10 years.... TEN FN YEARS... this is the greatest comeback since lazarus



 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.5¢
Change
0.001(11.1%)
Mkt cap ! $15.86M
Open High Low Value Volume
0.4¢ 0.5¢ 0.4¢ $1.68K 370K

Buyers (Bids)

No. Vol. Price($)
52 48699073 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 5068251 5
View Market Depth
Last trade - 10.03am 07/08/2025 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.